Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Politicians' Leadership Essential to Solve Industry Problems: Dr Aoki
October 30, 2006
- 4 Domestic Companies to File for Pre-pandemic Flu Vaccine in 2007
October 30, 2006
- REGULATORY NEWS IN BRIEF
October 30, 2006
- 21st Scientific Meeting of the International Society of Hypertension (ISH2006)
October 30, 2006
- METI to Investigate Needs for R&D Promotion Taxation System
October 30, 2006
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
October 30, 2006
- R&D NEWS IN BRIEF
October 30, 2006
- Korosho to Repeat Survey to Eliminate "Provisional Delivery"
October 30, 2006
- Agilent to Market Its Products in Its Own Name from February 2007
October 30, 2006
- HPB to Ask Companies for Their Views on Industry Growth Strategy
October 30, 2006
- NEW PRODUCTS LUMINOVIEW (LV200): Olympus Corporation
October 30, 2006
- BUSINESS NEWS IN BRIEF
October 30, 2006
- Korosho Sets Up Study Group to Expedite Approval of Medical Devices
October 30, 2006
- Korosho to Question Major Pharmacy Chains on What They Do to Promote Use of Generics
October 30, 2006
- MIC Medical Expands Medical Image Analysis Business
October 30, 2006
- HIB Urges Pharmacies to Help Promote Use of GE Drugs
October 30, 2006
- AdvaMed
October 30, 2006
- Taiyo Yakuhin Aims to Be "Most Trusted Generic Drug Company"
October 30, 2006
- MEDICAL DEVICE NEWS IN BRIEF
October 30, 2006
- 2006 Symposium of APEC Network on Pharma Regulatory Science
October 30, 2006
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…